Mesoblast Limited (MESO)
Ceasing to be a substantial holder
Ceasing to be a substantial holder
[Press Release] HUTCHMED Highlights Clinical Data to be Presented at the 2025 ESMO Asia Congress and the 2025 ASH Annual Meeting
HUTCHMED Highlights Clinical Data to be Presented at the 2025 ESMO Asia Congress and the 2025 ASH Annual Meeting
UTHR: Notification
UTHR: Notification
UTHR: Notification
Beyond Air® Announces Transition of Chief Financial Officer
Zoetis - Zoetis Receives European Commission Marketing Authorization for Lenivia® (izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in Dogs
Zoetis Receives European Commission Marketing Authorization for Lenivia® (izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in Dogs
UTHR: Notification